Los Angeles Capital Management LLC Dynavax Technologies Corp Transaction History

Los Angeles Capital Management LLC

  • $28.5 Billion
  • Q3 2025

A detailed history of Los Angeles Capital Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 29,470 shares of DVAX stock, worth $306,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,470
Previous 32,350 8.9%
Holding current value
$306,488
Previous $320,000 8.75%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025
SELL
$9.36 - $11.36 $26,956 - $32,716
-2,880 Reduced 8.9%
29,470 $292,000
Q2 2025

Aug 06, 2025
BUY
$9.4 - $12.87 $304,090 - $416,344
32,350 New
32,350 $320,000
Q4 2023

Feb 06, 2024
SELL
$13.09 - $14.98 $202,868 - $232,160
-15,498 Reduced 19.55%
63,774 $891,000
Q3 2023

Nov 06, 2023
BUY
$12.64 - $14.99 $21,475 - $25,468
1,699 Added 2.19%
79,272 $1.17 Million
Q2 2023

Aug 03, 2023
SELL
$9.85 - $13.17 $38,483 - $51,455
-3,907 Reduced 4.8%
77,573 $1 Million
Q1 2023

May 04, 2023
SELL
$9.44 - $11.88 $11,601 - $14,600
-1,229 Reduced 1.49%
81,480 $799,000
Q4 2022

Feb 06, 2023
BUY
$10.27 - $13.29 $389,007 - $503,398
37,878 Added 84.49%
82,709 $880,000
Q3 2022

Nov 02, 2022
BUY
$9.93 - $17.44 $280,264 - $492,226
28,224 Added 169.95%
44,831 $468,000
Q2 2022

Aug 05, 2022
SELL
$7.45 - $12.83 $16,471 - $28,367
-2,211 Reduced 11.75%
16,607 $209,000
Q1 2022

May 06, 2022
BUY
$9.75 - $14.44 $183,475 - $271,731
18,818 New
18,818 $204,000
Q4 2021

Feb 03, 2022
SELL
$13.17 - $20.94 $762,345 - $1.21 Million
-57,885 Closed
0 $0
Q3 2021

Nov 08, 2021
SELL
$9.16 - $19.83 $306,493 - $663,511
-33,460 Reduced 36.63%
57,885 $1.11 Million
Q2 2021

Aug 05, 2021
SELL
$7.25 - $10.99 $329,795 - $499,924
-45,489 Reduced 33.24%
91,345 $900,000
Q1 2021

May 05, 2021
BUY
$4.57 - $11.18 $467,611 - $1.14 Million
102,322 Added 296.48%
136,834 $1.35 Million
Q4 2020

Feb 04, 2021
BUY
$3.73 - $5.6 $128,729 - $193,267
34,512 New
34,512 $154,000
Q3 2018

Nov 05, 2018
SELL
$11.85 - $16.0 $129,508 - $174,864
-10,929 Closed
0 $0
Q2 2018

Jul 31, 2018
SELL
$15.15 - $20.75 $76,189 - $104,351
-5,029 Reduced 31.51%
10,929 $167,000
Q1 2018

Apr 27, 2018
BUY
$14.65 - $19.9 $233,784 - $317,564
15,958 New
15,958 $317,000

Others Institutions Holding DVAX

# of Institutions
293
Shares Held
120M
Call Options Held
294K
Put Options Held
86.1K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.32B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email